宜明昂科生物医药技术（上海）股份有限公司（股票代码：01541）于2026年7月22日进行股份回购，涉及64,200股H股，占公司当日已发行股本（不包括库藏股）约0.0153%。回购价格区间为每股3.40港元至3.50港元，合计耗资约22.09万港元。
回购完成后，公司已发行股本总数维持在420,477,305股，其中不包括库藏股的部分为418,562,705股，库藏股数升至1,914,600股。公司回购授权于2026年5月28日获通过，授权可回购股份总数为43,150,769股，截至目前已根据该授权回购1,914,600股。
公司确认已遵守香港联交所证券上市规则及相关法律法规，公告由执行董事、联席公司秘书关梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.